from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2865/relF

LFCtreatmentdescriptionclass of inhibitor

1.059

Amikacinug/mL Amikacintranslation

0.451

Cap5-10ug/mL Capreomycintranslation

1.248

Rox10-50 ug/mL Roxithromycintranslation

0.761

SM2-5 ug/mL Streptomycintranslation

2.495

Tet5-10 ug/mL Tetracyclinetranslation

-0.399

Rif0.2-5ug/mL Rifampicintranscription

-0.822

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.665

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.315

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.420

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.603

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.933

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.010

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.655

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.508

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.223

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.063

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.487

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.619

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.770

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.392

KCN5-20 ug/mL Potassium cyaniderespiration

-0.270

NaN30.2-2 mM Sodium aziderespiration

-0.274

Nigericin50 uM Nigericinrespiration

0.317

TRC10-150 ug/mL Triclosanrespiration

1.354

TRZ10-25 ug/mL Thioridazinerespiration

1.139

Valinomycin0.5-10 uM Valinomycinrespiration

0.358

ZnSO42 mM ZnSO4respiration

0.460

menadione6-10 ug/mL Menadionerespiration

-0.570

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.363

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.537

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.083

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.441

NRP_1Non-replicating persistence stage 1dosRassociated

-0.019

Amp0.2mg/mL AmpicillincellWall

0.112

Cephalexin20-100 ug/mL CephalexincellWall

0.287

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.115

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.217

EMB10-20 ug/mL EthambutolcellWall

0.157

Eta12-40 ug/mL EthionamidecellWall

0.827

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.221

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.555

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.402

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.377

BZA0.12 mg/mL BenzamidearomaticAmides

0.165

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.472

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.110

H2O24 mM hydrogen peroxideDNAdamaging

-0.596

Levo10 ug/mL LevofloxacinDNAdamaging

-0.553

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.928

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.712

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.691

UVUV-irradiationDNAdamaging

-0.458

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.859

Antimycin12.5-50 ug/mL Antimycin A?

-0.234

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.110

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.492

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.010

PA8240.2-2 ug/mL PA-824?

0.433

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.334

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.070

Verapamil50 uM Verapamil?

-0.277

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.623

methoxatin10-20 ug/mL Methoxatin?